Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.42 Million | -19.37 Million | -26.42 Million | -8.39 Million | 161.12 Million | 70.7 Million |
| Net Income | -39.29 Million | -73.2 Million | -32.78 Million | -51.54 Million | 52.06 Million | -5.67 Million |
| Depreciation & Amortization | 15.01 Million | 18.34 Million | 12.3 Million | 8.66 Million | 12.63 Million | 13.32 Million |
| Deferred income taxes | 15.37 Thousand | 1.18 Million | -728.95 Thousand | 137.33 Thousand | -961.94 Thousand | 49.55 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.09 Million | -6.42 Million | -30.27 Million | -14.53 Million | 146.99 Million | 66.75 Million |
| Other non-cash items | 8.39 Million | 41.91 Million | 24.33 Million | 49.02 Million | -50.56 Million | -3.7 Million |
| Investing Cash Flow | -8.82 Million | -5.79 Million | -4.15 Million | -11.25 Million | -157.62 Million | -20.14 Million |
| Investments in PPE | -8.95 Million | -3.51 Million | -4.71 Million | -11.83 Million | -94.65 Million | -37.46 Million |
| Acquisitions | 1.00 | -2.2 Million | 555.38 Thousand | 2.55 Million | 1.47 Million | - |
| Investment purchases | - | - | - | -13.3 Million | -59.84 Million | -54.14 Million |
| Sales/Maturities of investments | - | - | - | 12.07 Million | -1.47 Million | 54.14 Million |
| Other Investing Activities | -38.86 Thousand | -81.78 Thousand | 0.01 | -753.08 Thousand | -3.12 Million | 17.31 Million |
| Financing Cash Flow | 84.82 Million | 56.05 Million | 34.52 Million | 7.51 Million | -70.35 Million | -4.63 Million |
| Debt repayment | -105 Thousand | -112.55 Million | -145.83 Million | -124.51 Million | -143.5 Million | -125.1 Million |
| Dividends payments | -6.66 Million | -4.77 Million | -6.7 Million | -7 Million | -6.08 Million | -9.24 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 91.59 Million | 173.38 Million | 187.05 Million | 139.03 Million | 79.23 Million | 129.71 Million |
| Accounts receivables | -6.41 Million | 43.19 Million | -27.41 Million | -35.88 Million | 54.88 Million | 21.68 Million |
| Accounts payables | -11.57 Million | -49.65 Million | -13.92 Million | 31.32 Million | 85.22 Million | 51.72 Million |
| Inventory | 4.86 Million | -1.14 Million | 11.79 Million | -10.1 Million | 7.84 Million | -6.7 Million |
| Other working capital | -11.55 Million | 1.18 Million | -728.95 Thousand | 137.33 Thousand | -961.94 Thousand | 73.46 Million |
| Cash at beginning of period | 42.39 Million | 11.5 Million | 7.56 Million | 19.7 Million | 86.55 Million | 40.62 Million |
| Cash at end of period | 97.96 Million | 42.39 Million | 11.5 Million | 7.56 Million | 19.7 Million | 86.55 Million |
| Capital Expenditure | -8.95 Million | -3.51 Million | -4.71 Million | -11.83 Million | -94.65 Million | -37.46 Million |
| Effect of forex changes on cash | - | - | - | - | 0.67 | - |
| Net cash flow / Change in cash | 55.57 Million | 30.88 Million | 3.94 Million | -12.14 Million | -66.84 Million | 45.92 Million |
| Free Cash Flow | -29.38 Million | -22.88 Million | -31.13 Million | -20.23 Million | 66.47 Million | 33.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.8 Million | -8.77 Million | -9.72 Million | -10.81 Million | -39.29 Million | -4.03 Million |
| Depreciation & Amortization | - | 4.28 Million | 4.28 Million | 15.01 Million | 15.01 Million | -8.03 Million |
| Deferred income taxes | - | - | - | - | 15.37 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -11.36 Million | - | -1.54 Million | -13.09 Million | 461.37 Thousand |
| Other non-cash items | -25.63 Million | -11.49 Million | 6.14 Million | 5.79 Million | 8.39 Million | 12.97 Million |
| Investing Cash Flow | -4.76 Million | -6.91 Million | -3.05 Million | -4.55 Million | -8.82 Million | -1.79 Million |
| Investments in PPE | -8.59 Million | -2.81 Million | -857.65 Thousand | -4.72 Million | -8.95 Million | -1.75 Million |
| Acquisitions | 3.46 Million | -4.46 Million | -2.2 Million | 38.86 Thousand | 1.00 | 1.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 358.6 Thousand | 30.00 | - | 129.11 Thousand | -38.86 Thousand | -38.86 Thousand |
| Financing Cash Flow | -22.17 Million | 27.83 Million | -35.41 Million | -6.88 Million | 84.82 Million | 94.84 Million |
| Debt repayment | -67.35 Million | -305 Thousand | -30.3 Million | -90.1 Million | -105 Thousand | -53 Million |
| Dividends payments | - | -1.02 Million | -1.53 Million | -1.99 Million | -6.66 Million | -1.56 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -89.53 Million | 32.12 Million | -3.56 Million | 85.22 Million | 91.59 Million | 149.4 Million |
| Accounts receivables | - | -1.09 Million | - | -6.41 Million | -6.41 Million | 973.56 Thousand |
| Accounts payables | - | - | - | - | -11.57 Million | - |
| Inventory | - | -10.27 Million | - | 4.86 Million | 4.86 Million | -512.19 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 71.31 Million | 55.92 Million | 97.96 Million | 100.94 Million | 42.39 Million | 6.52 Million |
| Cash at end of period | 30.42 Million | 52.27 Million | 55.92 Million | 97.96 Million | 97.96 Million | 100.94 Million |
| Capital Expenditure | -8.59 Million | -2.81 Million | -857.65 Thousand | -4.72 Million | -8.95 Million | -1.75 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.01 |
| Net cash flow / Change in cash | -40.88 Million | -3.64 Million | -42.04 Million | -2.98 Million | 55.57 Million | 94.42 Million |
| Free Cash Flow | -19.42 Million | -27.36 Million | -4.43 Million | 3.72 Million | -29.38 Million | -383.44 Thousand |
KSIOF
3497
0KU1
5902
6737
GFL